ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28887323.
- Also identified by DOI 10.1158/0008-5472.CAN-17-0907 and PMC identifier 5718045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autophagy mediates resistance to various anticancer agents. In melanoma, resistance to targeted therapy has been linked to expression of Wnt5A, an intrinsic inhibitor of β-catenin, which also promotes invasion. In this study, we assessed the interplay between Wnt5A and autophagy by combining expression studies in human clinical biopsies with functional analyses in cell lines and mouse models. Melanoma cells with high Wnt5A and low β-catenin displayed increased basal autophagy. Genetic blockade of autophagy revealed an unexpected feedback loop whereby knocking down the autophagy factor ATG5 in Wnt5A<sup>high</sup> cells decreased Wnt5A and increased β-catenin. To define the physiologic relevance of this loop, melanoma cells with different Wnt status were treated <i>in vitro</i> and <i>in vivo</i> with the potent lysosomotropic compound Lys05. Wnt5A<sup>high</sup> cells were less sensitive to Lys05 and could be reverted by inducing β-catenin activity. Our results suggest the efficacy of autophagy inhibitors might be improved by taking the Wnt signature of melanoma cells into account. <i>Cancer Res; 77(21); 5873-85. ©2017 AACR</i>.
Medical subject headings
- Autophagy
- Autophagy-Related Protein 5
- Melanoma
- Wnt Signaling Pathway